Price Alert

Cocrystal Pharma Inc. (COCP)

NASDAQ: COCP · Real-Time Price · USD

1.70

0.02 (1.19%)

At close: Aug 15, 2025, 3:59 PM

1.72

1.11%

After-hours: Aug 15, 2025, 04:31 PM EDT

Cocrystal Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	6.92M	9.86M	13.02M	18.14M	21.92M	26.43M	29.74M	32.42M	33.98M	37.14M	42.06M	51.03M	54.79M	58.7M	61.64M	67.06M	33.28M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	86K	29K	29K	29K	46K	46K	46K	46K	46K	46K	46K	46K	46K	46K	46K	46K	46K
Receivables	1.45M	1.22M	n/a	1.08M	1M	890K	550K	1.21M	956K	716K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	75K	75K	75K	75K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	460K	505K	1.24M	440K	1.65M	1.85M	1.92M	2.13M	2.22M	2.32M	75K	75K	50K	50K	125K	50K	50K
Total Current Assets	8.83M	11.58M	14.26M	19.66M	24.49M	29.09M	32.2M	35.76M	37.24M	40.18M	44.9M	51.6M	55.4M	59.32M	62.44M	67.34M	33.69M
Property-Plant & Equipment	1.75M	1.85M	1.95M	1.88M	2.01M	2.12M	363K	472K	559K	616K	705K	741K	835K	931K	1.02M	942K	1.02M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	19.09M	19.09M	19.09M	19.09M	19.09M
Total Long-Term Assets	1.83M	1.88M	1.98M	1.91M	2.05M	2.17M	409K	518K	605K	662K	751K	787K	19.97M	20.07M	20.16M	20.08M	20.16M
Total Assets	10.66M	13.46M	16.23M	21.57M	26.55M	31.26M	32.61M	36.28M	37.84M	40.84M	45.65M	52.38M	75.37M	79.39M	82.6M	87.42M	53.85M
Account Payables	808K	1.54M	859K	1.74M	1.23M	1.22M	568K	1.04M	2.65M	614K	897K	616K	858K	578K	491K	939K	748K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-568K	n/a	n/a	n/a	n/a	n/a	n/a	719K	470K	1.2M	446K
Short-Term Debt	n/a	301K	n/a	251K	n/a	240K	118K	166K	n/a	240K	241K	242K	243K	236K	233K	190K	203K
Other Current Liabilities	100K	468K	185K	253K	766K	1.45M	947K	64K	n/a	-8K	75K	1.57M	83K	-120K	113K	-5K	161K
Total Current Liabilities	1.93M	2.43M	1.95M	2.65M	2.38M	3.26M	1.92M	1.59M	3.15M	1.22M	1.62M	2.81M	1.56M	1.54M	1.23M	2.38M	1.46M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.42M	1.5M	1.58M	1.53M	1.58M	1.61M	n/a	10K	27K	57K	119K	177K	234K	298K	358K	290K	336K
Total Liabilities	3.35M	3.93M	3.53M	4.18M	3.96M	4.88M	1.92M	1.6M	3.17M	1.27M	1.74M	2.99M	1.79M	1.84M	1.59M	2.67M	1.79M
Total Debt	1.73M	1.81M	1.88M	1.78M	1.82M	1.85M	118K	176K	235K	297K	360K	419K	477K	534K	591K	480K	539K
Common Stock	10K	10K	10K	10K	10K	10K	10K	10K	8K	8K	8K	98K	98K	98K	98K	98K	72K
Retained Earnings	-335.72M	-333.42M	-330.15M	-325.21M	-319.87M	-315.91M	-311.45M	-307.29M	-303.12M	-297.93M	-293.43M	-287.73M	-263.3M	-259.09M	-255.41M	-251.47M	-247.65M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	0.00	0.00	n/a	n/a	-0.00	n/a	-0.00	n/a	-1.16M
Shareholders Equity	7.3M	9.52M	12.7M	17.39M	22.59M	26.38M	30.69M	34.68M	34.67M	39.57M	43.91M	49.39M	73.58M	77.55M	81.01M	84.75M	52.06M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a